Fosun Pharma executes share buyback program

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX:2196) announced a share repurchase program executed on March 26, 2025. The company repurchased 812,800 ordinary shares on the Shanghai Stock Exchange at prices ranging from RMB 24.54 to RMB 24.66, for a total consideration of RMB 19,990,858.63. Additionally, Fosun Pharma repurchased 673,500 H-shares on the Hong Kong Stock Exchange at prices between HKD 14.74 and HKD 14.96, totaling HKD 9,975,190. Following these transactions, the total number of treasury shares held by the company is 6,490,500 ordinary shares and 9,214,000 H-shares. The buyback reflects the company's ongoing capital management strategy and commitment to shareholder value.